Description

Nebacumab CAS NO 138661-01-5 is a monoclonal antibody specifically developed for therapeutic applications. This compound is critical for its targeted action in clinical and research settings, offering high specificity and efficacy. It is primarily required by pharmaceutical manufacturers, biotechnology research institutions, and clinical diagnostic developers for advanced therapeutic and investigative purposes.

Application

• Therapeutic Agent Development: Primary use in the research and formulation of targeted biologic therapies.
• Clinical Research: Utilized as a key reagent in preclinical and clinical studies for specific disease pathways.
• Biopharmaceutical Manufacturing: Serves as an active pharmaceutical ingredient (API) or intermediate in the production of monoclonal antibody-based drugs.
• Diagnostic Assay Development: Used in the creation of sensitive and specific immunoassays and diagnostic kits.
• Life Science Research: A vital tool in immunology, oncology, and infectious disease research for studying antibody-antigen interactions.

Basic Information

Product Name	Nebacumab
CAS No.	138661-01-5
Molecular Formula	Contact for details
Molecular Weight	Contact for details
Synonyms	HA-1A; Nebacumab (INN); Anti-lipid A monoclonal antibody HA-1A; Human monoclonal antibody HA-1A; Monoclonal antibody HA-1A; Centoxin (former brand name); Anti-endotoxin monoclonal antibody HA-1A
EINECS	Contact for details

Quality Control

Our Nebacumab is produced and tested under stringent quality management systems to ensure it meets the high standards required for pharmaceutical and research use. Each batch undergoes comprehensive analytical testing, including purity, potency, and identity verification. Certificates of Analysis (COA) documenting compliance with relevant specifications are available upon request.

Storage

Preserve in a tightly closed container, protected from light. Store at 2-8°C. This product is strictly light-sensitive and hygroscopic; it must be protected from all light exposure and stored under conditions that prevent moisture absorption. For long-term stability, avoid repeated freeze-thaw cycles.

Specification

Item	Specification
Appearance	White to off-white lyophilized powder or clear solution
Identification (HPLC/Immunoassay)	Conforms
Purity (SDS-PAGE / SEC-HPLC)	≥ 95.0%
Protein Content (UV Absorbance)	As per COA
Endotoxin Level (LAL)	< 1.0 EU/mg
Sterility (Membrane Filtration)	Sterile
pH	6.5 - 7.5

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.